See the ViSi Mobile™ System Patient Monitoring Technology at 2012 HIMSS Conference & Exhibition – #HIMSS12

LAS VEGASFebruary 20, 2012 – Last month, ViSi Mobile™ System was highlighted by Paul Jacobs, Qualcomm CEO, in his keynote at the Consumer Electronics Show. You can see this new wireless patient monitoring system, currently under FDA review, at the annual HIMSS Conference & Exhibition from Tuesday, February 21 – Friday, February 23.

WHERE:Sotera will be in two locations at the conference, the Qualcomm Wireless Health Pavilion (#13234) and the Burwood booth (#8310) both at the Venetian Conference Center.

WHEN:February 20-24, 2012

WHAT: The ViSi Mobile System is designed to keep clinicians connected to their patients, whether they are bedridden or ambulatory, using a small wrist-worn device. Sotera collaborated with Carlsbad, Calif.-based DD Studio to design this elegant system, which measures and displays core vital signs critical to patient care. Sotera has completed device development and is developing features that will enable comprehensive wireless transmission of data to computers and mobile devices, along with the addition of novel sensing technologies.

Studies conducted worldwide have consistently shown that patients in any hospital setting may suffer preventable adverse events that could result in prolonged hospitalization, injury or death. Currently, continuous monitoring systems, which would allow for identifying emerging problems, are typically used only in high-acuity areas of the hospital, such as intensive care units (ICU). In lower acuity areas, which host 60 to 70 percent of hospitalized patients, vital signs are typically collected via spot checks that are conducted at four to six hour intervals.

About Sotera Wireless

Sotera Wireless, Inc. is a San Diego, California based medical device company dedicated to the development, marketing and sale of a new generation of comprehensive vital signs monitoring. Sotera’s mission is to improve patient safety by empowering clinicians to detect early signs of deterioration in virtually any care setting and enable early intervention and rapid response, all without limiting the patient’s freedom of movement. More information on the company can be obtained at or by sending an email to